the aid library

LIST OPTIONS

Filter

8258

Sort by:

Direction:

Download (32)

View PDF (77)

Chronic HIV Care with ARV Therapy and Prevention

World Health Organization (2007) C_WHO

Integrated Management of Adolescent and Adult Illness Integrated Management of Childhood Illness Interim Guidelines for health workers at health centre or district hospital outpatient clinic

Download (283)

View PDF (560)

Keputusan Menteri Kesehatan Republik Indonesia Nomor 781/MENKES/SK/VII/2004 tentang Penetapan Rumah Sakit Rujukan Bagi Orang dengan HIV/AIDS

Ministry of Health Republic of Indonesia (2004) C1

Decree of the Minister of Health of the Republic of Indonesia Number 781 / MENKES / SK / VII / 2004 on the establishment of referral hospital for people with HIV / AIDS

Download (94)

View PDF (1015)

Chain-free initiative

World Health Organization WHO (2019) CC

The chain-free initiative evolved in response to an urgent need to: provide technical and financial support for hospital reform, improve domestic conditions for people with mental illness, develop community care programmes, raise mental health literacy in the community and among health workers, and ... more

Download (156)

View PDF (2298)

Auto-Visual AFP Detection and Reporting (AVADAR)

eHealth Africa Bill & Melinda Gates Foundation (2019) CC

AVADAR is a mobile sms-based software application designed to improve the quality and sensitivity of Acute Flaccid Paralysis (AFP) surveillance by health workers and key informants within hospital facilities and local communities. The idea is simple: Health workers visit remote villages to check if... more

Download (3243)

View PDF (1236)

Pratique chirurgicale de base dans les structures à moyens limités

Organisation Mondiale de la Santé OMS (2011)

Cet ouvrage est l’adaptation en langue française d’un des livres les plus demandés de l’OMS: Surgical Care at the District Hospital. Il y a longtemps qu’il était attendu notamment par l’Afrique francophone. En effet l’ambition de ce livre est de contribuer à corriger l’insuffisance... more

Download (231)

View PDF (1308)

Spectrum. Localized antimicrobial stewardship

Alberta Health Services, Canada, et al. (2018) C1

Spectrum is a mobile app that can be customized to deliver local antimicrobial stewardship resources in any hospital. Spectrum delivers all of your clinical pathways directly to the point of care. Each guideline is presented in an algorithmic format for ease of use and can incorporate individualize... more

Download (147)

View PDF (1094)

Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing

Evangelina IN, Inês T, Miguelhete L et al (2016) CC

This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique. BMC Infectious Diseases (2016) 16:423 DO... more

Download (127)

View PDF (1825)

MSF Medical Guidelines App

Medécins sans Frontières (2017) C2

This diagnostic and treatment manual is designed for use by medical professionals involved in cura- tive care at the dispensary and hospital levels. We have tried to respond in the simplest and most practical way possible to the questions and problems faced by field medical staff... more

Download (121)

View PDF (114)

Handbook of COVID-19 Prevention and Treatment
recommended

Global MediXchange for Combating COVID-19 (GMCC) (2020) C1

Handbook of COVID-19 Prevention and Treatment, expecting to share their invaluable practical advice and references with medical staff around the world. This handbook compared and analyzed the experience of other experts in China, and provides good reference to key departments such as hospital infect... more

Download (34)

View PDF (598)

Essential medicines access survey in public hospitals of Burkina Faso

Saouadogo H., M. Compaore African Journal of Pharmacy and Pharmacology (2010) C2

During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm... more

Download (29)

View PDF (992)

Nepal Improving antibiotic use for UTIs in Nepal – Examples from the field

ReAct (2018) C2

This small scale project aimed to optimize antibiotic prescriptions for Urinary Tract Infections (UTI) at Okhaldhunga Community Hospital in Nepal. A review of 18 months data from urine cultures taken in the hospital was completed in 2017. Presentations about antibiotic resistance, the local bacteria... more

Download (58)

View PDF (100)

Para equipos de profesionales que intervienen: Regulación emocional basada en Mindfulness (REM) en la crisis sanitaria COVID19

Comunidad de Madrid -Ministerio de Salud (2020) C1

Regulación emocional basada en Mindfulness (REM) en la crisis sanitaria COVID19 Para equipos de profesionales que intervienen Marzo 2020 Hospital Universitario la Paz. Servicio de. Psiquiatría, Psicología clínica y Salud Mental Lo siguiente es un guía sencilla para aproximarse a los equipos... more

Download (48)

View PDF (83)

Support for Rehabilitation: Self-Management after COVID-19 Related Illness (Ukraine Version)

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

Download (39)

View PDF (69)

Support for Rehabilitation: Self-Management after COVID-19 Related Illness (Greek Version)

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

Download (87)

View PDF (105)

Cardiac Rehabilitation Change Package

Centers for Disease Control and Prevention (CDC) (2018) CC

This Cardiac Rehabilitation Change Package was completed by the Centers for Disease Control and Prevention (CDC) in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) with the purpose of helping cardiac rehabilitation programs, hospital quality improv... more

Download (60)

View PDF (817)

Major trauma backpack 2021

World Health Organization WHO (2021) C_WHO

The WHO Trauma Bag 2021 is intended to provide the resources needed to care for care of acutely ill and injured patients in hospital emergency units, field hospitals or clinics providing acute care. The Trauma Bag may also be applicable in prehospital settings if care is provided by advanced practi... more

Download (270)

View PDF (190)

Antibiotic Guidelines, 2019 (First edition) - Myanmar

World Health Organization WHO (2019) C_WHO

This is the first edition of Empiric Antibiotic Guidelines, as a guidance to all medical practitioners at North Okklapa General & Teaching Hospital. Antibiotics are critical in the management of infection and can have a significant impact in reducing morbidity and mortality. Emerging antimicrobia... more

Download (82)

View PDF (136)

Patient safety assessment manual
recommended

World Health Organization WHO (2022) C_WHO

3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO gu... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Handbook of COVID-19 Prevention and Treatment recommended

Patient safety assessment manual recommended

Handbook of COVID-19 Prevention and Treatment
recommended

Patient safety assessment manual
recommended